March 9, 2020 / 10:23 AM / a month ago

BRIEF-CSPC says Rivaroxaban Tablets Developed By Unit Gets Drug Registration Approval By NMPA

March 9 (Reuters) - CSPC Pharmaceutical Group Ltd:

* CSPC PHARMACEUTICAL GROUP LTD- RIVAROXABAN TABLETS DEVELOPED BY UNIT GRANTED DRUG REGISTRATION APPROVAL BY NMPA OF PRC Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below